Skip to main content
Premium Trial:

Request an Annual Quote

Wipro Restructures to Broaden Healthcare and Life Sciences Offerings

Premium

Citing a market opportunity of around $25 billion, growing at over 20 percent annually, Bangalore, India-based IT firm Wipro Limited has created a new segment to focus on healthcare and life science. The company appointed D. A. Prasanna, currently vice chairman of Wipro, to head up the new unit.

Wipro Healthcare and Life Science has a broad mandate, ranging from the development of bioinformatics tools and other discovery informatics, to new technology for electronic FDA submissions, to IT solutions for hospitals and health insurance companies.

Prasanna is also on the board of Wipro GE Medical Systems Limited, a joint venture between Wipro and GE that makes up the bulk of the company’s current activity in the life sciences market. The new segment will comprise the Wipro Healthcare vertical, with customers in hospitals and health insurance companies, along with Wipro Biomed, which currently addresses the IT needs of manufacturers of medical and life science devices.

Wipro spokesman Vijay Gupta explained, “Currently we are an IT company going to healthcare. Wipro Healthcare and Life Science is a healthcare team going with IT solutions.”

Custom bioinformatics solutions will be developed for Wipro customers, Gupta said, but specific details on the technology planned for this purpose were not available.

Gupta noted that “a significant portion” of Wipro’s future total business is expected to come from the HLS group.

— BT

Filed under

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.